CIK 0001734750 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Corvex, Inc.
Sign in to watch- Ticker
- MOVE
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824233771
- Phone
- 866-438-4787
- Business address
- 3401 NORTH FAIRFAX DRIVE, ARLINGTON, VA, 22226
- Former names
- Movano Inc., Maestro Sensors Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | Caballero Ruben Director | Option exercise | +29,197 | $0.92 | $27K | 38,017 |
| 2026-06-25 | Caballero Ruben Director | Option exercise · Stock Options (Right to Buy) | −29,197 | 0 | ||
| 2026-03-31 | Demsey Seth Director | Conversion | +24,532 | 3,078,767 | ||
| 2026-03-31 | Demsey Seth Director | Conversion | +139 | 139 | ||
| 2026-03-31 | Demsey Seth Director | Conversion · Series B Preferred Stock | −24.53 | 0 | ||
| 2026-03-31 | Demsey Seth Director | Conversion · Series B Preferred Stock | −0.14 | 0 | ||
| 2026-03-31 | Crystal John Adler III Chief Executive Officer | Conversion | +14,965 | 3,069,200 | ||
| 2026-03-31 | Crystal John Adler III Chief Executive Officer | Conversion | +3,167 | 3,167 | ||
| 2026-03-31 | Crystal John Adler III Chief Executive Officer | Conversion · Series B Preferred Stock | −14.97 | 0 | ||
| 2026-03-31 | Crystal John Adler III Chief Executive Officer | Conversion · Series B Preferred Stock | −3.17 | 0 | ||
| 2026-03-31 | FAIRBAIRN EMILY Director | Conversion | +9,231 | 9,231 | ||
| 2026-03-31 | FAIRBAIRN EMILY Director | Conversion · Series B Preferred Stock | −9.23 | 0 | ||
| 2026-03-19 | FAIRBAIRN EMILY Director | Grant or award · Series B Preferred Stock | +9.23 | 9.23 | ||
| 2026-03-19 | FAIRBAIRN EMILY Director | Grant or award · Series C Preferred Stock | +2,063.82 | 2,063.82 | ||
| 2026-03-18 | FAIRBAIRN EMILY Director | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2026-03-18 | Cogan Jeremy CFO | Grant or award | +37,000 | 97,504 | ||
| 2026-03-16 | FAIRBAIRN EMILY Director | Option exercise | +55,250 | $1.25 | $69K | 68,369 |
| 2026-03-16 | FAIRBAIRN EMILY Director | Option exercise · Stock Options (Right to Buy) | −55,250 | 0 | ||
| 2026-03-13 | Wirk Shaheen Director | Option exercise | +10,000 | $1.25 | $13K | 15,960 |
| 2026-03-13 | Wirk Shaheen Director | Option exercise · Stock Options (Right to Buy) | −10,000 | 0 |
Page 2 of 9 · 176 trades